CAR T Cell Therapy for Patients with Solid Tumours: Key Lessons to Learn and Unlearn

The author re-evaluates current data and suggest potential pathways towards greater success, drawing lessons from the few successful trials testing CAR T cells in patients with solid tumors and the clinical experience with tumor-infiltrating lymphocytes.